Sponsor or institution
Clinical trials and research at First Affiliated Hospital of Harbin Medical University
As of November 12, 2026, Find a Trial lists 5 clinical trials run by First Affiliated Hospital of Harbin Medical University that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Early evolocumab plus statin for large-artery ischemic stroke | — | Heilongjiang | Recruiting | Apr 20, 2026 |
| Ketone esters for aging T cells and inflammation in older adults | — | Harbin, Heilongjiang | Recruiting | Jul 25, 2025 |
| Using Human Urinary Kallidinogenase to Treat Acute Ischemic Stroke | — | Harbin, Heilongjiang | Recruiting | Nov 20, 2024 |
| Exploring VISTA Levels in Patients with Vascular Cognitive Impairment | — | Harbin, Heilongjiang | Recruiting | Apr 2, 2024 |
| Using low-dose Decitabine with COP chemotherapy for relapsed DLBCL | — | Harbin, Heilongjiang | Recruiting | Apr 11, 2018 |
All recruiting trials (5)
-
Early evolocumab plus statin for large-artery ischemic stroke
This will test whether giving evolocumab with a statin soon after a large-artery ischemic stroke helps people recover better than a statin alone.
-
Ketone esters for aging T cells and inflammation in older adults
This will test whether taking a ketone ester can reduce senescent T cells and inflammation in healthy adults aged 65–80.
-
Using Human Urinary Kallidinogenase to Treat Acute Ischemic Stroke
This study is testing whether a treatment called Human Urinary Kallidin can help reduce inflammation and improve recovery in people who have just had an acute ischemic stroke.
-
Exploring VISTA Levels in Patients with Vascular Cognitive Impairment
This study is testing how levels of a protein called VISTA in the blood and spinal fluid relate to cognitive problems in people with heart and blood vessel issues over several years.
-
Using low-dose Decitabine with COP chemotherapy for relapsed DLBCL
This study is testing if adding a low dose of Decitabine to standard chemotherapy can help people with relapsed diffuse large B-cell lymphoma who haven't responded to other treatments.
Quick answers
How many clinical trials run by First Affiliated Hospital of Harbin Medical University are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.